{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T20:22:38Z","timestamp":1769372558824,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"26","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The very long-term outcome of patients who survive the first few years after receiving cardiac resynchronization therapy (CRT) has not been well described thus far. We aimed to provide long-term outcomes, especially with regard to the occurrence of sudden cardiac death (SCD), in CRT patients without (CRT-P) and with defibrillator (CRT-D).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A total of 1775 patients, with ischaemic or non-ischaemic dilated cardiomyopathy, who were alive 5\u2009years after CRT implantation, were enrolled in this multicentre European observational cohort study. Overall long-term mortality rates and specific causes of death were assessed, with a focus on late SCD. Over a mean follow-up of 30\u2009months (interquartile range 10\u201342\u2009months) beyond the first 5\u2009years, we observed 473 deaths. The annual age-standardized mortality rates of CRT-D and CRT-P patients were 40.4 [95% confidence interval (CI) 35.3\u201345.5] and 97.2 (95% CI 85.5\u2013109.9) per 1000 patient-years, respectively. The adjusted hazard ratio (HR) for all-cause mortality was 0.99 (95% CI 0.79\u20131.22). Twenty-nine patients in total died of late SCD (14 with CRT-P, 15 with CRT-D), corresponding to 6.1% of all causes of death in both device groups. Specific annual SCD rates were 8.5 and 5.8 per 1000 patient-years in CRT-P and CRT-D patients, respectively, with no significant difference between groups (adjusted HR 1.0, 95% CI 0.45\u20132.44). Death due to progressive heart failure represented the principal cause of death (42.8% in CRT-P patients and 52.6% among CRT-D recipients), whereas approximately one-third of deaths in both device groups were due to non-cardiovascular death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In this first description of very long-term outcomes among CRT recipients, progressive heart failure death still represented the most frequent cause of death in patients surviving the first 5 years after CRT implant. In contrast, SCD represents a very low proportion of late mortality irrespective of the presence of a defibrillator.<\/jats:p>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehz238","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T03:15:41Z","timestamp":1554347741000},"page":"2121-2127","source":"Crossref","is-referenced-by-count":32,"title":["Very long-term survival and late sudden cardiac death in cardiac resynchronization therapy patients"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-3767","authenticated-orcid":false,"given":"S\u00e9rgio","family":"Barra","sequence":"first","affiliation":[{"name":"Cardiology Department, Hospital da Luz Arrabida, V. N. Gaia, Portugal"},{"name":"Cardiology Department, V. N. Gaia Hospital Center, V. N. Gaia, Portugal"},{"name":"Department of Cardiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Duehmke","sequence":"additional","affiliation":[{"name":"Cardiology Department, West Suffolk Hospital, West Suffolk, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Provid\u00eancia","sequence":"additional","affiliation":[{"name":"Cardiology Department, Barts Heart Centre, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Cardiology Department, MaxCure Hospitals, Hyderabad, India"},{"name":"Paris Cardiovascular Research Center (Inserm U970), Cardiovascular Epidemiology Unit, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Reitan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Arrhythmia Clinic, Lund University, Skane University Hospital, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Roubicek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rostislav","family":"Polasek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Chow","sequence":"additional","affiliation":[{"name":"Cardiology Department, Barts Heart Centre, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Defaye","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, University Hospital, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, Centre Hospitalier Universitaire Trousseau, Tours, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Fran\u00e7ois Rabelais, Tours, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Piot","sequence":"additional","affiliation":[{"name":"Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Deharo","sequence":"additional","affiliation":[{"name":"Cardiology Division, H\u00f4pital La Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sadoul","sequence":"additional","affiliation":[{"name":"Cardiology Division, Nancy University Hospital, Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Klug","sequence":"additional","affiliation":[{"name":"Cardiology Division, Lille University Hospital and University of Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigue","family":"Garcia","sequence":"additional","affiliation":[{"name":"Cardiology Division, Poitiers University Hospital, Poitiers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Dockrill","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munmohan","family":"Virdee","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Pettit","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Papworth Hospital NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus","family":"Borgquist","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Arrhythmia Clinic, Lund University, Skane University Hospital, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloi","family":"Marijon","sequence":"additional","affiliation":[{"name":"Paris Cardiovascular Research Center (Inserm U970), Cardiovascular Epidemiology Unit, Paris, France"},{"name":"Cardiology Department, European Georges Pompidou Hospital, Paris, France"},{"name":"Paris Descartes University, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-3544","authenticated-orcid":false,"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Cardiology Department, Clinique Pasteur, Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"2022102608532372600_ehz238-B1","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"2022102608532372600_ehz238-B2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/eurjhf\/hfs055","article-title":"Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial","volume":"14","author":"Cleland","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2022102608532372600_ehz238-B3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/clc.22658","article-title":"Predictors and long-term outcome of super-responders to cardiac resynchronization therapy","volume":"40","author":"Ghani","year":"2017","journal-title":"Clin Cardiol"},{"key":"2022102608532372600_ehz238-B4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/europace\/eux094","article-title":"Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis","volume":"20","author":"Barra","year":"2018","journal-title":"Europace"},{"key":"2022102608532372600_ehz238-B5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/heartjnl-2016-310677","article-title":"Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure","volume":"103","author":"Barra","year":"2017","journal-title":"Heart"},{"key":"2022102608532372600_ehz238-B6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102608532372600_ehz238-B7","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jacc.2017.01.042","article-title":"Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate","volume":"69","author":"Barra","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102608532372600_ehz238-B8","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/eurheartj\/ehv455","article-title":"Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study","volume":"36","author":"Marijon","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102608532372600_ehz238-B9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102608532372600_ehz238-B10","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1401426","article-title":"Survival with cardiac-resynchronization therapy in mild heart failure","volume":"370","author":"Goldenberg","year":"2014","journal-title":"N Engl J Med"},{"key":"2022102608532372600_ehz238-B11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/europace\/euv352","article-title":"Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy","volume":"18","author":"Barra","year":"2016","journal-title":"Europace"},{"key":"2022102608532372600_ehz238-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.115.002756","article-title":"Primary prevention implantable cardioverter defibrillator (ICD) therapy in women-data from a multicenter french registry","volume":"5","author":"Provid\u00eancia","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2022102608532372600_ehz238-B13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/pace.12631","article-title":"Long-term results of cardiac resynchronization therapy: a comparison between CRT-pacemakers versus primary prophylactic CRT-defibrillators","volume":"38","author":"Reitan","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022102608532372600_ehz238-B14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCEP.115.003004","article-title":"Left ventricular lead electrical delay is a predictor of mortality in patients with cardiac resynchronization therapy","volume":"8","author":"Roubicek","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022102608532372600_ehz238-B15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2017.06.056","article-title":"Impact of an age-adjusted co-morbidity index on survival of patients with heart failure implanted with cardiac resynchronization therapy devices","volume":"120","author":"Ioannou","year":"2017","journal-title":"Am J Cardiol"},{"key":"2022102608532372600_ehz238-B16","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"2022102608532372600_ehz238-B17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/europace\/euv109","article-title":"Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer","volume":"17","author":"Landolina","year":"2015","journal-title":"Europace"},{"key":"2022102608532372600_ehz238-B18","first-page":"421","article-title":"Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports","volume":"19","author":"Alam","year":"2017","journal-title":"Europace"},{"key":"2022102608532372600_ehz238-B19"},{"key":"2022102608532372600_ehz238-B20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","article-title":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement","volume":"134","author":"Austin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022102608532372600_ehz238-B21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.recesp.2014.01.017","article-title":"Ventricular arrhythmias in super-responders to cardiac resynchronization therapy","volume":"67","author":"Garc\u00eda-Lunar","year":"2014","journal-title":"Rev Esp Cardiol"},{"key":"2022102608532372600_ehz238-B22","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","article-title":"Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT study","volume":"59","author":"Hsu","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022102608532372600_ehz238-B23","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.jacc.2011.08.038","article-title":"Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders","volume":"58","author":"Thijssen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022102608532372600_ehz238-B24","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.114.011283","article-title":"Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy","volume":"130","author":"Ruwald","year":"2014","journal-title":"Circulation"},{"key":"2022102608532372600_ehz238-B25","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurjhf\/hfq171","article-title":"Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients","volume":"12","author":"Schaer","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2022102608532372600_ehz238-B26","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/europace\/eux357","article-title":"Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy","volume":"20","author":"Leyva","year":"2018","journal-title":"Europace"},{"key":"2022102608532372600_ehz238-B27","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.jacc.2013.07.080","article-title":"Quantification of survival gain from cardiac resynchronization therapy: nonlinear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behavior","volume":"62","author":"Finegold","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102608532372600_ehz238-B28","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2015-307634","article-title":"Individual patient data network meta-analysis of mortality effects of implantable cardiac devices","volume":"101","author":"Woods","year":"2015","journal-title":"Heart"},{"key":"2022102608532372600_ehz238-B29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/heartjnl-2017-312546","article-title":"Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention","volume":"104","author":"Barra","year":"2018","journal-title":"Heart"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/26\/2121\/46639179\/eurheartj_40_26_2121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/26\/2121\/46639179\/eurheartj_40_26_2121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T08:58:10Z","timestamp":1666774690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/26\/2121\/5482553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":29,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2019,5,2]]},"published-print":{"date-parts":[[2019,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz238","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,7]]},"published":{"date-parts":[[2019,5,2]]}}}